Asahi Kasei appeared to be the Corporate Investor, which was created in 1931. The venture was found in Asia in Japan. The leading representative office of defined Corporate Investor is situated in the Tokyo.
The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Health Care, Clinical Trials. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Atox Bio, Artisan Pharma, Arcterus.
The high activity for fund was in 2019. Considering the real fund results, this Corporate Investor is 25 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Asahi Kasei works on 20 percentage points less the average amount of lead investments.
The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Asahi Kasei, startups are often financed by New Leaf Venture Partners, Tribeca Venture Partners, Pritzker Group Venture Capital. The meaningful sponsors for the fund in investment in the same round are Z-kai, Yuval Tal, Tribeca Venture Partners. In the next rounds fund is usually obtained by General Motors Ventures, Z-kai, Vincent Deltrieu.
|CIC Capital||France, Ile-de-France, Paris|
|Mill Rock Capital||New York, New York, United States|
|Ronglian Chuangfu||Beijing, China, Haidian|
|RZN8 Capital||Kentucky, Louisville, United States|
|The Unofficial Syndicate||-|
|TNG Fintech Group Inc.||China, Hong Kong, Hong Kong Island|
|Tokyo Gas||Chiyoda, Japan|
|Trolley Venture Partners||Richmond, United States, Virginia|
|XL Axiata Tbk||Indonesia, Jakarta, Jakarta Raya|
|$10M||16 Jan 2023||London, England, United Kingdom|
|$42M||03 Dec 2022||California, United States|
|$12M||17 Nov 2022||The Hague, South Holland, Netherlands|
|$2M||06 Jul 2022||Ann Arbor, Michigan, United States|
|05 Jun 2022||Chiyoda, Japan|
|$2M||01 Jan 2022||Jerusalem, Jerusalem District, Israel|
|$32M||19 Oct 2021||New York, New York, United States|
|$30M||03 Aug 2021||California, United States|
|$35M||23 Jun 2021||San Francisco, California, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.